Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)
Status:
Completed
Trial end date:
2004-06-16
Target enrollment:
Participant gender:
Summary
The clinical study evaluates the safety of montelukast and compares montelukast to ketotifen,
used as a control drug, in terms of improvement in morning peak expiratory flow (am pef) over
first 2 weeks in patients with pediatric bronchial asthma aged 6 to < 15.
The effect of body weight on the efficacy and safety of montelukast will also be evaluated in
this study.